Blaise Aguirre Net Worth

Blaise Aguirre biography

Dr. Blaise A. Aguirre, MD, has been appointed as Director of the Company. He received his Medical Doctor’s degree in 1989 from the University of the Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994. He is an Assistant Professor of Psychiatry at Harvard Medical School and he is the founding Medical Director of 3East at McLean Hospital. Dr. Aguirre is fluent in Spanish and lectures worldwide. He was elected to the Board at Investors Capital Holdings, Ltd in 2011 and remained on the Board until it was sold to RCAP. He sits on the boards of various privately held companies. He developed and maintains enduring relationships with institutional money managers, venture capitalists, Angel investors and developed an expertise as a small cap stock analyst as a broker with series 7 and 63 securities licenses.

How old is Blaise Aguirre?

Blaise Aguirre is 55, he's been the Director of United States Antimony since 2019. There are 6 older and 6 younger executives at United States Antimony. The oldest executive at United States Antimony Corp. is John C. Gustavsen, 72, who is the Interim CEO & Exec. VP.

What's Blaise Aguirre's mailing address?

Blaise's mailing address filed with the SEC is 47 COX GULCH ROAD, , THOMPSON FALLS, MT, 59873.

Insiders trading at United States Antimony

Over the last 21 years, insiders at United States Antimony have traded over $1,417,384 worth of United States Antimony stock and bought 2,168,295 units worth $31,108,967 . The most active insiders traders include Gary C Evans, Russ C Lawrence und Kenneth M Reed. On average, United States Antimony executives and independent directors trade stock every 107 days with the average trade being worth of $75,193. The most recent stock trade was executed by Richard R Isaak on 9 September 2024, trading 5,000 units of UAMY stock currently worth $3,450.

What does United States Antimony do?

united states antimony corporation produces and sells antimony, silver, gold, and zeolite products in the united states and canada. the company's antimony division offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper. its antimony oxide is also used as a color fastener in paints; as a catalyst for the production of polyester resins for fibers and films; as a catalyst for the production of polyethelene pthalate in plastic bottles; as a phosphorescent agent in fluorescent light bulbs; and as an opacifier for porcelains. in addition, this division offers sodium antimonite for use as a fining agent for glass in cathode ray tubes, and as a flame retardant; antimony metal for use in bearings, storage batteries, and ordnance; and precious metals. the company's zeolite division provides zeolite deposits for soil amendment and fertilizer, water filtrati

United States Antimony executives and stock owners

United States Antimony executives and other stock owners filed with the SEC include:

• Daniel Parks,
  Chief Financial Officer
• Russell Lawrence,
  Vice President, Director
• Russell C. Lawrence,
  Pres & Director
• John C. Gustavsen,
  Interim CEO & Exec. VP
• John Gustavsen,
  Interim Chief Executive Officer
• Blaise Aguirre,
  Director
• Jeffrey Wright,
  Director
• Craig Thomas,
  Director
• Hartmut Baitis,
  Director
• Alicia Hill,
  Controller, Treasurer, Secretary
• Matthew Keane,
  Vice President
• Alicia Hill,
  Sec., Controller & Treasurer
• Nick Taylor,
  Corp. Counsel
• Kelly J. Stopher,
  Chief Financial Officer
• Michael A Jr Mcmanus,
  
• Rachel Hubert,
  Controller
• Bernard John Guarnera,
  Director
• Kenneth Mreed Susan K Reed,
  
• Patrick W Dugan,
  Director
• Kenneth M Reed,
  10% owner
• Lydia Dugan,
  10% owner
• Joseph A Carrabba,
  
• Richard R Isaak,
  SVP, Chief Financial Officer
• Whitney H. Ferer,
  
• Gary D Babbitt,
  
• Timothy Hasara,
  
• Al W Dugan,
  10% owner
• John C Lawrence,
  President
• Gary C Evans,
  Chairman & Co-CEO
• Lloyd Bardswich,
  Director & Co-CEO
• Russ C Lawrence,
  President